Phosphorylation of Insig-2 mediates inhibition of fatty acid synthesis by polyunsaturated fatty acids
Proceedings of the National Academy of Sciences · 20.08.2024 · 121 (34)
DOI: 10.1073/pnas.2409262121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 15.08.2024. Verfasst von Jing Tian und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75390. Hauptthemen laut MEDLINE: Membrane Proteins, Sterol Regulatory Element Binding Protein 1, Intracellular Signaling Peptides and Proteins, Cyclic AMP-Dependent Protein Kinases. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, HHS | NIH (NIH).
Abstract (Originalsprache)
Insig-1 and Insig-2 are endoplasmic reticulum (ER) proteins that inhibit lipid synthesis by blocking transport of sterol regulatory element-binding proteins (SREBP-1 and SREBP-2) from ER to Golgi. In the Golgi, SREBPs are processed proteolytically to release their transcription-activating domains, which enhance the synthesis of fatty acids, triglycerides, and cholesterol. Heretofore, the two Insigs have redundant functions, and there is no rationale for two isoforms. The current data identify a specific function for Insig-2. We show that eicosapentaenoic acid (EPA), a polyunsaturated fatty acid, inhibits fatty acid synthesis in human fibroblasts and rat hepatocytes by activating adenylate cyclase, which induces protein kinase A (PKA) to phosphorylate serine-106 in Insig-2. Phosphorylated Insig-2 inhibits the proteolytic processing of SREBP-1, thereby blocking fatty acid synthesis. Phosphorylated Insig-2 does not block the processing of SREBP-2, which activates cholesterol synthesis. Insig-1 lacks serine-106 and is not phosphorylated at this site. EPA inhibition of SREBP-1 processing was reduced by the replacement of serine-106 in Insig-2 with alanine or by treatment with KT5720, a PKA inhibitor. Inhibition did not occur in mutant human fibroblasts that possess Insig-1 but lack Insig-2. These data provide an Insig-2-specific mechanism for the long-known inhibition of fatty acid synthesis by polyunsaturated fatty acids.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75390.
ORCID-Profile: Jing Tian, Joseph L Goldstein, Shili Li, Marc M Schumacher, Michael S Brown
Förderung
- NHLBI NIH HHS
- NIDDK NIH HHS
- HHS | NIH (NIH)
Zitieren
APA
Tian, J., Goldstein, J. L., Li, S., Schumacher, M. M., & Brown, M. S. (2024). Phosphorylation of Insig-2 mediates inhibition of fatty acid synthesis by polyunsaturated fatty acids. Proceedings of the National Academy of Sciences, 121(34). https://doi.org/10.1073/pnas.2409262121
Vancouver
Tian J, Goldstein JL, Li S, Schumacher MM, Brown MS. Phosphorylation of Insig-2 mediates inhibition of fatty acid synthesis by polyunsaturated fatty acids. Proceedings of the National Academy of Sciences. 2024;121(34). doi:10.1073/pnas.2409262121
BibTeX
@article{Tian2024,
author = {Tian, Jing and Goldstein, Joseph L and Li, Shili and Schumacher, Marc M and Brown, Michael S},
title = {Phosphorylation of Insig-2 mediates inhibition of fatty acid synthesis by polyunsaturated fatty acids},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
volume = {121},
number = {34},
doi = {10.1073/pnas.2409262121}
}
EUVIMED